FANCA and Friedreich ataxia: When FA‐A LCLs were treated both with the ZFNs and the PGK‐FANCA/PuroR IDLV, a significant decrease in the hypersensitivity of these FA cells to MMC was observed, showing the complementation by gene editing of these cells (Fig 2B).